In Situ Hybridization Market Opportunities and Trends Report 2024

"The Business Research Company recently released a comprehensive report on the Global In Situ Hybridization Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The in situ hybridization market size has grown strongly in recent years. It will grow from $1.57 billion in 2023 to $1.72 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to early adoption in research, evolution of molecular biology tools, diagnostic applications development, shift in biomedical research focus, increasing investment in biotechnology..

The in situ hybridization market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing adoption in clinical diagnostics, growth in research and development funding, automation and high-throughput solutions, expanded applications in neuroscience and pathology.. Major trends in the forecast period include advancements in molecular biology, rising demand in research applications, diagnostic applications expansion, demand for personalized medicine, increased funding in biomedical research..

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Market Drivers and Trends:

Increasing infectious diseases are expected to propel the growth of the in-situ hybridization market going forward. Infectious diseases refer to conditions that transmit from one individual to another via polluted foods and beverages and through pathogens such as viruses, bacteria, fungi, and parasites. By utilizing labeled nucleic acid sequences (probes) particular to the infectious organism, in situ hybridization (ISH) seeks to identify complementary nucleic acid sequences that are present in the tissue, so an increasing infectious disease boosts the growth of the in-situ hybridization market. For instance, in December 2022, according to the Annual Epidemiological Report for 2021 published by the European Centre for Disease Prevention and Control, a Sweden-based European government health agency, the distribution of hepatitis C cases and rates per 100,000 population in Germany reached 4,718 cases and 5.7 rates, respectively, from 4,536 cases and 5.5 rates. Therefore, increasing infectious diseases are driving the growth of the in-situ hybridization market.

Technological developments are the key trend gaining popularity in the -situ hybridization market. Major companies operating in the in-situ hybridization market are focusing on the development of technologies to sustain their position in the market. For instance, in April 2021, Bio-Techne Corporation, a US-based biotech company engaged in the manufacturing and commercialization of science reagents, and instruments, launched RNAscope technology and marketed a new DNAscope Assays. The RNAscope technology is an enhanced in situ hybridization (ISH) technique that allows direct visualization of single-molecule transcription with single-cell resolution in unaltered cells and tissues. Since DNAscope uses the tried-and-true 'double-Z' probe design and signal enhancement system of RNAscope, it can swiftly and easily create probes for any DNA target and allow for target visualization in formalin-fixed paraffin-embedded (FFPE) tissues.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10476&type=smp

Major Key Players of the Market:

Thermo Fisher Scientific Inc.; Bio SB Inc.; BioGenex Laboratories; Advanced Cell Diagnostics Inc.; Exiqon A/S; Agilent Technologies Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories Inc.; Merck KGaA; PerkinElmer Inc.; Biocare Medical LLC; Genemed Biotechnologies; Danaher Corporation; Leica Biosystems Nussloch GmbH; Bio-Rad Laboratories Inc.; Oxford Gene Technology; Abnova Corporation; Qiagen; Bio-Techne Corporation; Biochain Institute Inc.; Cytocell Ltd.; Enzo Life Sciences Inc.; Eurofins Scientific SE; FISH Technologies Sdn Bhd; Genetix Biotech Asia Pvt. Ltd.; Zytomed System GmbH; AdvanDx Inc.; Affymetrix Inc.; Akoya Biosciences Inc.; Becton Dickinson and Company (BD); Cell Signaling Technology Inc.; DAKO Systemtechnik und Service GmbH & Co; Life Technologies; Molecular Devices LLC.; NanoString Technologies Inc.; Visiopharm A/S

In Situ Hybridization Market 2024 Key Insights:

• The in situ hybridization market will grow to $2.51 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%.
• The Surging Role Of In-Situ Hybridization In Tackling Infectious Diseases
• Technological Trends Steering The In-Situ Hybridization Market
• North America was the largest region in the in situ hybridization market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10476&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.